EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for TTRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Amgen, Inc. 5.934
Nektar Therapeutics -1.875
Bluejay Diagnostics, Inc. -1.015
Apogee Therapeutics, Inc. -1.106
CEL-SCI Corp. -1.365

EPS Diluted (Quarterly) Related Metrics